SCHEMBL4640585

SCHEMBL4640585

c1ccc(-c2ncnc3ccccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 1.00
GRM4 Q14833 1/20 0.58
PIK3CD O00329 1/20 0.55
PIK3CA P42336 1/20 0.55
PIK3CB P42338 1/20 0.55
MTOR P42345 1/20 0.55
PIK3CG P48736 1/20 0.55
LMNA P02545 2/20 0.53
HTT P42858 1/20 0.53
PI4KA P42356 1/20 0.52
PI4K2B Q8TCG2 1/20 0.52
PI4K2A Q9BTU6 1/20 0.52
PI4KB Q9UBF8 1/20 0.52
PDE4A P27815 1/20 0.52
PDE4B Q07343 1/20 0.52
PDE4C Q08493 1/20 0.52
PDE4D Q08499 1/20 0.52
NUDT1 P36639 3/20 0.52
JAK2 O60674 1/20 0.52
KDM4E B2RXH2 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29398384 1.00 ADORA2A (1.00) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL31022155 0.98 ADORA2A (0.96) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL15815414 0.96 ADORA2A (0.92) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL29986426 0.96 ADORA2A (0.92) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
Formaldehyde SCHEMBL28253268 0.94 ADORA2A (0.89) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL24184593 0.89 ADORA2A (0.79) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL20233979 0.89 ADORA2A (0.79) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL15811022 0.88 ADORA2A (0.79) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL24596492 0.87 ADORA2A (0.76) ADORA2AGRM4PIK3CDPIK3CAPIK3CB
SCHEMBL3075421 0.86 ADORA2A (0.75) ADORA2AGRM4LMNAHTTPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4200310-B1 SPIRO-CYCLOMETALATED IRIDIUM EMITTERS FOR OLED APPLICATIONS UNIV HONG KONG (CN) 2025-11-05 EP claimed
US-20250311689-A1 SEEDLING GERMINATION AND GROWTH CONDITIONS PIONEER HI-BRED INTERNATIONAL, INC. (US) 2025-10-09 US claimed
CN-118459506-A Iridium complex capable of preparing efficient device by using 4-pyrimidine formic acid as auxiliary ligand in solution 云南师范大学 2024-08-09 CN claimed
US-20230357294-A1 SPIRO-CYCLOMETALATED IRIDIUM EMITTERS FOR OLED APPLICATIONS THE UNIVERSITY OF HONG KONG (HK) 2023-11-09 US claimed
CN-116377458-A Method for electrochemically synthesizing quinazoline derivative 安徽科技学院 2023-07-04 CN claimed
CN-116157490-A Spiro metallized iridium emitters for OLED applications 香港大学 2023-05-23 CN claimed
WO-2023056236-A1 SEEDLING GERMINATION AND GROWTH CONDITIONS PIONEER HI-BRED INTERNATIONAL, INC. (US) 2023-04-06 WO claimed
WO-2022037613-A1 SPIRO-CYCLOMETALATED IRIDIUM EMITTERS FOR OLED APPLICATIONS THE UNIVERSITY OF HONG KONG (CN) 2022-02-24 WO claimed
CN-107698522-A The preparation method of the phenylquinazoline of 6 chlorine, 3 amino, 3,4 dihydro, 4 hydroxyl 4 华中药业股份有限公司 2018-02-16 CN claimed
CN-106632086-A 2-(2-iodoaryl)quinazoline compound and preparation method thereof 江西省林业科学院 2017-05-10 CN claimed
US-9273012-B2 Facile preparation of 4-substituted quinazolines and related heterocycles UNIVERSITY OF HOUSTON SYSTEM (US) 2016-03-01 US claimed
WO-2013050527-A1 QUINAZOLINE DERIVATIVES AS PDE10A ENZYME INHIBITORS H. LUNDBECK A/S (DK) 2013-04-11 WO claimed
US-20080217582-A1 CLASS OF LUMINESCENT IRIDIUM(III) COMPLEXES WITH 2-(DIPHENYLPHOSPHINO)PHENOLATE LIGAND AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF CHI, YUN (TW) 2008-09-11 US claimed
EP-1954782-A1 ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER EASTMAN KODAK COMPANY (US) 2008-08-13 EP claimed
WO-2007064479-A1 ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER EASTMAN KODAK COMPANY (US) 2007-06-07 WO claimed
US-20070122655-A1 Electroluminescent device with quinazoline complex emitter EASTMAN KODAK COMPANY 2007-05-31 US claimed
EP-0079810-B1 DERIVATIVES OF 4-PHENYL-QUINAZOLINE ACTIVE ON THE CENTRAL NERVOUS SYSTEM SANOFI S.A. (FR) 1986-01-22 EP claimed
US-4499092-A ANTIEPILEPTIC AGENTS SANOFI (FR) 1985-02-12 US claimed
EP-4200310-B1 SPIRO-CYCLOMETALATED IRIDIUM EMITTERS FOR OLED APPLICATIONS UNIV HONG KONG (CN) 2025-11-05 EP disclosed
US-4175964-A SUCCESSIVE SURFACE TREATMENT WITH AQUEOUS SOLUTIONS OF PHOSPHORIC ACID AND SILICIC ACID OR ITS SALTS FUJI PHOTO FILM CO., LTD. (JP) 1979-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357294-A1 SPIRO-CYCLOMETALATED IRIDIUM EMITTERS FOR OLED APPLICATIONS TALDO1, SRD5A1, SRD5A2 ADORA2A 2436/4885GRM4 3389/4885PIK3CD 2872/4885
US-20080217582-A1 CLASS OF LUMINESCENT IRIDIUM(III) COMPLEXES WITH 2-(DIPHENYLPHOSPHINO)PHENOLATE LIGAND AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF IK, ITPR3, ITPR2 ADORA2A 3857/4885GRM4 2029/4885PIK3CD 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.